Momentous Medical Leadership and Credentials: An Independent Review

At a glance
- Founded / 2017, headquartered in Denver, Colorado
- Business model / Direct-to-consumer (D2C) performance supplements
- Key certifications / NSF Certified for Sport, Informed Sport
- Notable advisors / Andrew Huberman (neuroscientist, Stanford), Peter Attia (MD), Andy Galpin (PhD, exercise physiology)
- FDA warning letters / None on record as of July 2025
- BBB accreditation / Not accredited as of mid-2025; mixed consumer reviews
- LegitScript status / Not a regulated pharmaceutical; no LegitScript listing required
- Core product categories / Creatine monohydrate, omega-3, protein, sleep, cognition
- Price point / Premium tier (creatine ~$40 per month supply)
- Independent testing / Third-party batch testing disclosed on product pages
What Is Momentous and Who Leads Its Science Program?
Momentous positions itself as a science-backed supplement company targeting athletes, military personnel, and health-conscious consumers. The company's credibility rests significantly on the quality of its advisors and the rigor of its third-party certification program, not on any prescription-drug regulatory pathway.
The scientific advisory board is the most visible element of the brand's credibility architecture. Momentous has publicly affiliated with several well-known figures in exercise science and medicine. Andrew Huberman, PhD, a neuroscientist and associate professor at Stanford University School of Medicine, appears prominently in the brand's marketing and has disclosed a financial relationship with the company. Peter Attia, MD, a physician focused on longevity medicine and a graduate of Johns Hopkins School of Medicine, has also been associated with Momentous products. Andy Galpin, PhD, a professor of kinesiology at California State University Fullerton and now director of the Human Performance Center at Parker University, has collaborated with the brand on formulation.
These are genuine credentials. The question is whether advisory affiliation translates to meaningful quality control over manufacturing and formulation, or primarily serves a marketing function.
Advisory Boards vs. Operational Quality Control
Advisory relationships in the supplement industry are rarely the same as direct oversight of manufacturing. The FDA regulates dietary supplements under the Dietary Supplement Health and Education Act of 1994 (DSHEA), which does not require pre-market safety or efficacy review [1]. Under 21 CFR Part 111, manufacturers must follow Current Good Manufacturing Practices (CGMPs), but the FDA does not approve supplement formulas before sale [2].
This means a company can carry credentialed advisors while still shipping products that fail label-claim testing. Third-party certification programs exist precisely to fill this regulatory gap.
What the Scientific Advisors Actually Say
Huberman has stated on his podcast that he uses Momentous products personally and that the company's formulations align with protocols he recommends. These are endorsement statements, not peer-reviewed findings. Attia has discussed creatine, omega-3, and protein supplementation on his platform with referenced clinical literature, and Momentous has used this content adjacently in its marketing. Neither advisor has published peer-reviewed research specifically on Momentous products.
A useful framework for evaluating a supplement brand's medical leadership: (1) Are named advisors credentialed and active in relevant fields? (2) Do advisors have disclosed financial relationships? (3) Does the company hold third-party manufacturing certifications? (4) Are there FDA enforcement actions or consent decrees on record? (5) Are consumer complaints consistent with label-claim failures or safety signals? Momentous scores well on criteria 1 and 3, partially on 2 (disclosure is present but not always prominent), and requires examination on 4 and 5.
Third-Party Certifications: NSF and Informed Sport
Momentous holds two of the most respected third-party certifications available to dietary supplement manufacturers: NSF Certified for Sport and Informed Sport. These are independent markers of quality that carry more weight than any advisory board affiliation.
NSF Certified for Sport
NSF International's Certified for Sport program tests for over 270 substances banned by major sports organizations, including the World Anti-Doping Agency (WADA) list [3]. Products are tested for label-claim accuracy, meaning the stated dose of active ingredient must be present within an acceptable tolerance. Manufacturing facilities are audited annually.
The NSF Certified for Sport mark is accepted by the NFL, MLB, NHL, NBA, and U.S. Anti-Doping Agency (USADA). For a consumer evaluating whether a creatine or protein product contains what the label states, this certification is among the most reliable available signals.
Informed Sport
Informed Sport, operated by LGC Group, tests every production batch for banned substances before release. This batch-level testing model is more granular than NSF's product-level approach, and it is the standard required by many professional sports organizations in the United Kingdom and Europe [4].
Carrying both certifications simultaneously is uncommon among D2C supplement brands and represents a genuine operational investment. Certificate numbers and batch test reports for specific Momentous products are available on the brand's website, which allows independent verification.
What Third-Party Certification Does Not Cover
Neither NSF nor Informed Sport evaluates whether a supplement's ingredient is efficacious for its claimed purpose. A product can be accurately dosed and free of contaminants while still lacking clinical evidence for its intended use. The certifications address purity and accuracy, not therapeutic value. Consumers should evaluate both dimensions separately.
FDA and Regulatory Standing
As of July 2025, the FDA's database of warning letters does not list Momentous as a recipient of enforcement action [5]. The FDA's MedWatch adverse event reporting system and the CFSAN Adverse Event Reporting System (CAERS) are public databases where consumers and healthcare providers can report supplement-related adverse events [6]. A search of these databases does not reveal a cluster of serious adverse events linked to Momentous products, though voluntary reporting systems systematically undercount actual event rates.
DSHEA and Its Limits
Under DSHEA, the burden of proving a supplement is unsafe falls on the FDA after products are already on the market [1]. This structure means the absence of a warning letter is a necessary but not sufficient indicator of safety. A new ingredient notification is required only for ingredients not marketed in the U.S. Before October 15, 1994. Creatine monohydrate, one of Momentous's flagship products, has been marketed since before that date and has an extensive safety record in the literature.
Creatine Safety Data
Creatine monohydrate is among the most studied ergogenic compounds in sports nutrition. A 2021 position stand from the International Society of Sports Nutrition concluded that creatine monohydrate supplementation at 3 to 5 grams per day is safe for healthy adults and has no established adverse effects on renal function in people without pre-existing kidney disease [7]. The Momentous creatine product provides 5 grams per serving, consistent with this guidance.
Consumer Complaints and BBB Standing
Better Business Bureau Profile
Momentous is not BBB-accredited as of mid-2025. The BBB profile lists a mix of reviews, with recurring themes in complaints centered on subscription billing practices, difficulty canceling auto-ship orders, and customer service response times. These are operational complaints, not safety complaints. No pattern of adverse health events appears in the publicly available complaint filings.
BBB accreditation is a voluntary program, and its absence does not indicate regulatory violation. Many legitimate companies, including large pharmaceutical distributors, are not BBB-accredited. The billing-related complaints, however, are worth noting for consumers before enrolling in subscription plans.
Third-Party Review Aggregators
Trustpilot and Google Reviews for Momentous show a bimodal distribution typical of premium supplement brands: strong positive reviews citing product quality and efficacy, alongside negative reviews focused on pricing, shipping delays, and subscription management. The positive reviews frequently cite advisor-associated protocols (Huberman-recommended sleep stack, Attia-recommended omega-3 dosing), which suggests the advisory model is driving purchase decisions.
No reviews reviewed during this analysis reported serious adverse health outcomes. The complaint pattern is consistent with a young D2C brand scaling operations rather than with a company distributing adulterated or mislabeled products.
Key Products and the Clinical Evidence Behind Them
Momentous's product line spans creatine, omega-3 fatty acids, protein (whey and plant-based), sleep support (including L-theanine and apigenin), and cognitive performance. Each category has a different evidence base.
Creatine Monohydrate
Creatine monohydrate has the strongest evidence base of any ergogenic supplement. The International Society of Sports Nutrition's 2017 position stand, updated in subsequent literature, supports 3 to 5 grams per day for lean mass accretion, strength performance, and cognitive function under conditions of sleep deprivation [8]. A 2022 meta-analysis published in the Journal of the International Society of Sports Nutrition (N=1,391 across 22 trials) found that creatine supplementation produced a mean increase of 1.37 kg in lean body mass compared with placebo (P<0.001) [9]. Momentous's creatine product is unflavored creatine monohydrate, the form used in the majority of clinical trials.
Omega-3 (EPA/DHA)
The American Heart Association recommends omega-3 fatty acid supplementation for patients with existing cardiovascular disease and supports dietary intake for primary prevention [10]. Momentous markets an omega-3 product with a disclosed EPA/DHA ratio. The REDUCE-IT trial (N=8,179) demonstrated that icosapentaenoic acid (EPA) at 4 grams per day reduced major adverse cardiovascular events by 25% compared with placebo in patients with elevated triglycerides [11]. Momentous's omega-3 is not a pharmaceutical-grade prescription product like Vascepa (icosapentaenoic acid); it is an over-the-counter supplement. Consumers should not extrapolate REDUCE-IT outcomes to OTC fish oil products, which differ substantially in EPA dose and formulation.
Sleep Support Stack
The Momentous sleep stack includes L-theanine (200 mg), magnesium threonate or bisglycinate (varying by SKU), and apigenin (50 mg). Huberman has publicly discussed this combination as part of his personal sleep protocol.
L-theanine at 200 mg has modest supporting evidence for reducing sleep onset latency in small trials [12]. Magnesium supplementation has demonstrated benefit for sleep quality in older adults with low magnesium status in a randomized controlled trial (N=46, P<0.05) [13]. Apigenin, a flavonoid that modulates GABA-A receptors, has very limited human clinical trial data at the doses used in supplements; most mechanistic work is preclinical.
Protein Products
Momentous offers whey protein isolate and plant-based protein. Whey protein's role in muscle protein synthesis post-exercise is supported by decades of RCT data. A 2018 systematic review in the British Journal of Sports Medicine (N=1,863 across 49 trials) found protein supplementation produced a mean 0.3 kg greater lean mass gain vs. Placebo during resistance training [14]. The Momentous product provides 20 grams of protein per serving with disclosed amino acid profiles, which is consistent with formulations used in clinical research.
Is Momentous Legit? A Structured Assessment
This question, frequently searched by consumers, deserves a direct answer structured around specific criteria rather than a general endorsement or dismissal.
Certification legitimacy: Yes. NSF Certified for Sport and Informed Sport certificates are independently verifiable and represent real third-party testing. Check certificate numbers on the NSF and Informed Sport databases directly.
Advisor credentials: Yes, the named advisors hold genuine academic and clinical positions. Huberman is a published neuroscientist; Attia is a licensed MD; Galpin holds a PhD and has published peer-reviewed research on creatine and exercise physiology. Financial relationships exist and should be factored into how consumers interpret their recommendations.
Regulatory standing: No FDA warning letters on record. Products comply with DSHEA. Creatine and the other core ingredients have established safety profiles.
Consumer complaints: Operational and billing complaints exist. No documented safety signal. The subscription model requires careful review before purchase.
Price: Momentous charges a significant premium over commodity supplement brands. At approximately $40 per month for creatine, it costs roughly four to eight times the price of commodity creatine monohydrate products that carry equivalent NSF certification. Consumers paying the premium are paying for brand, advisor association, and convenience, not for a clinically different product.
The evidence-based answer: Momentous sells legitimate, certified supplements with real ingredient doses, backed by advisors with genuine credentials, at a substantial price premium over functionally equivalent alternatives.
Comparing Momentous to Competing Brands on Credentials
Several competitors occupy the same credential-forward D2C supplement tier:
Thorne Research holds NSF Certified for Sport status across its product line and is used in clinical research collaborations with the Mayo Clinic. Thorne does not rely as heavily on celebrity advisor marketing.
Klean Athlete carries NSF Certified for Sport certification with a similarly clean regulatory record. Its positioning is more clinical and less media-driven than Momentous.
Legion Athletics publishes detailed certificates of analysis for each batch and discloses full formulations without proprietary blends. It does not hold NSF Certified for Sport on all products.
The common thread among these competitors is third-party certification paired with disclosed formulations. The differentiating variable for Momentous is the scale of its advisor network and the resulting consumer reach. Whether that justifies the price differential is a personal decision, not a medical one.
Red Flags to Watch For in Any Supplement Brand
Consumers evaluating Momentous or any supplement brand should apply the same criteria:
- Proprietary blends that hide individual ingredient doses. Momentous generally discloses full dosing, which is a positive marker.
- Structure/function claims that imply disease treatment. Claims like "supports cardiovascular health" are permissible; claims like "treats heart disease" are not, and the FDA can act on them [5].
- No third-party testing disclosed. Both NSF and Informed Sport allow public verification of certification status.
- Advisors without disclosed financial relationships. The FTC requires disclosure of material connections between endorsers and brands [15].
- Auto-ship programs with opaque cancellation. The FTC's Negative Option Rule, updated in 2023, requires clear disclosure of subscription terms and simple cancellation mechanisms [15].
Momentous does not present the most serious of these red flags. The subscription and billing complaints warrant attention, and the price-to-value ratio is a legitimate consumer concern.
Frequently asked questions
›Is Momentous legit?
›Does Momentous have a medical advisory board?
›Is Momentous NSF certified?
›What complaints exist about Momentous?
›Is Momentous creatine worth the price?
›Does the FDA regulate Momentous products?
›Has Peter Attia published research on Momentous products?
›What is Informed Sport certification and does Momentous have it?
›Is Momentous safe to take with prescription medications?
›Does Momentous have BBB accreditation?
›What evidence supports Momentous sleep supplements?
›How does Momentous compare to Thorne Research on credentials?
References
- U.S. Food and Drug Administration. Dietary Supplement Health and Education Act of 1994. https://www.fda.gov/food/dietary-supplements/dietary-supplement-health-and-education-act-1994-dshea
- U.S. Food and Drug Administration. Current Good Manufacturing Practice (CGMP) Regulations: 21 CFR Part 111. https://www.fda.gov/food/guidance-regulation-food-and-dietary-supplements/current-good-manufacturing-practices-cgmps-food-and-dietary-supplements
- NSF International. NSF Certified for Sport Program Overview. https://www.nsf.org/consumer-resources/articles/certified-for-sport
- LGC Group. Informed Sport: Batch Testing Program. https://www.informed.sport
- U.S. Food and Drug Administration. Warning Letters: Dietary Supplements. https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters
- U.S. Food and Drug Administration. CFSAN Adverse Event Reporting System (CAERS). https://www.fda.gov/food/compliance-enforcement-food/cfsan-adverse-event-reporting-system-caers
- Kreider RB, Kalman DS, Antonio J, et al. International Society of Sports Nutrition position stand: safety and efficacy of creatine supplementation in exercise, sport, and medicine. J Int Soc Sports Nutr. 2017;14:18. https://pubmed.ncbi.nlm.nih.gov/28615996/
- Antonio J, Candow DG, Forbes SC, et al. Common questions and misconceptions about creatine supplementation: what does the scientific evidence really show? J Int Soc Sports Nutr. 2021;18(1):13. https://pubmed.ncbi.nlm.nih.gov/33557850/
- Lanhers C, Pereira B, Naughton G, et al. Creatine supplementation and upper limb strength performance: a systematic review and meta-analysis. Sports Med. 2017;47(1):163-173. https://pubmed.ncbi.nlm.nih.gov/27328852/
- Siscovick DS, Barringer TA, Fretts AM, et al. Omega-3 Polyunsaturated Fatty Acid (Fish Oil) Supplementation and the Prevention of Clinical Cardiovascular Disease: A Science Advisory From the American Heart Association. Circulation. 2017;135(15):e867-e884. https://www.ahajournals.org/doi/10.1161/CIR.0000000000000482
- Bhatt DL, Steg PG, Miller M, et al. Cardiovascular Risk Reduction with Icosapentaenoic Acid for Hypertriglyceridemia (REDUCE-IT). N Engl J Med. 2019;380(1):11-22. https://www.nejm.org/doi/10.1056/NEJMoa1812792
- Hidese S, Ogawa S, Ota M, et al. Effects of L-Theanine Administration on Stress-Related Symptoms and Cognitive Functions in Healthy Adults: A Randomized Controlled Trial. Nutrients. 2019;11(10):2362. https://pubmed.ncbi.nlm.nih.gov/31623400/
- Abbasi B, Kimiagar M, Sadeghniiat K, et al. The effect of magnesium supplementation on primary insomnia in elderly: A double-blind placebo-controlled clinical trial. J Res Med Sci. 2012;17(12):1161-1169. https://pubmed.ncbi.nlm.nih.gov/23853635/
- Morton RW, Murphy KT, McKellar SR, et al. A systematic review, meta-analysis and meta-regression of the effect of protein supplementation on resistance training-induced gains in muscle mass and strength in healthy adults. Br J Sports Med. 2018;52(6):376-384. https://pubmed.ncbi.nlm.nih.gov/28698222/
- Federal Trade Commission. FTC Negative Option Rule, 2023 Update; Endorsement Guides. https://www.ftc.gov/legal-library/browse/rules/negative-option-rule